Phase II trial of concurrent Nivolumab and radiation therapy in chemotherapy ineligible muscle invasive bladder cancer [NUTRA trial NCT03421652]

被引：0
|
作者：
George, Saby [2 ]
Heilbrun, Lance [1 ]
Maier, Jordan [3 ]
Dickow, Brenda [3 ]
Kuettel, Michael [2 ]
Frazier, Arthur [3 ]
Suisham, Stacey [3 ]
Parajuli, Prahlad [3 ]
Vaishampayan, Nitin [3 ]
Vaishampayan, Ulka [3 ]
机构：
[1] Wayne State Univ, Detroit, MI USA
[2] Roswell Pk, Buffalo, NY USA
[3] Karmanos Canc Ctr, Detroit, MI USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O24
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Effective bladder preservation strategy with low-dose radiation therapy and concurrent intrarrterial chemotherapy for muscle-invasive bladder cancer
    Hitoshi Ikushima
    Seiji Iwamoto
    Kyohsuke Osaki
    Shunsuke Furutani
    Kyoh Yamashita
    Takashi Kawanaka
    Akiko Kubo
    Yoshihiro Takegawa
    Takaharu Kudoh
    Hiroomi Kanayama
    Hiromu Nishitani
    Radiation Medicine, 2008, 26 : 156 - 163
  • [22] Concurrent Radiation Therapy (RT), Ipilimumab (Ipi) and/or Nivolumab (Nivo) on a Phase 1 Clinical Trial
    Barker, C. A.
    Postow, M. A.
    Kronenberg, S. A.
    Ma, J.
    Yamada, Y.
    Beal, K.
    Chan, T. A.
    Callahan, M. K.
    Wolchok, J. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S210 - S211
  • [23] A phase II clinical trial of toripalimab combined with cisplatin plus gemcitabine chemotherapy as neoadjuvant treatment for muscle-invasive bladder cancer
    Yang, Rong
    Li, Tianhang
    Zhang, Shun
    Zhang, Shiwei
    Guo, Hongqian
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [24] A phase III trial of neoadjuvant chemotherapy (NCT) in patients (PTS) with invasive bladder cancer (IBC). Preliminary results: NCT improves pathological complete response rate
    Marciello, E
    Tabernero, JM
    Villavicencio, H
    Algaba, F
    Maroto, P
    Huidobro, G
    Bellet, M
    Sola, C
    Chechile, G
    Caparros, J
    Guillen, V
    Solsona, E
    Lopez, JJ
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1155 - 1155
  • [25] Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer: a phase II trial
    Valérie Fonteyne
    Piet Dirix
    Sara Junius
    Elke Rammant
    Piet Ost
    Gert De Meerleer
    Martijn Swimberghe
    Karel Decaestecker
    BMC Cancer, 17
  • [26] Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer: a phase II trial
    Fonteyne, Valerie
    Dirix, Piet
    Junius, Sara
    Rammant, Elke
    Ost, Piet
    De Meerleer, Gert
    Swimberghe, Martijn
    Decaestecker, Karel
    BMC CANCER, 2017, 17
  • [27] Phase I/II trial of cetuximab with 5-fluorouracil and mitomycin C concurrent with radiotherapy in patients with muscle invasive bladder cancer.
    Hussain, Syed A.
    Buckley, Laura
    Kaur, Baljit
    Hendron, Carey
    Zarkar, Anjali
    Ford, Daniel
    Viney, Richard
    Syndikus, Isabel
    Malik, Zafar
    Eswar, Chinnamani
    Desai, Amisha
    Southgate, Elizabeth
    Mangar, Stephen
    Van Der Voet, Johannes
    Lydon, Anna
    James, Nicholas D.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [28] PrECOG PrE0807: A Phase 1b Feasibility Trial of Neoadjuvant Nivolumab Without and with Lirilumab in Patients with Muscle-invasive Bladder Cancer Ineligible for or Refusing Cisplatin-based Neoadjuvant Chemotherapy
    Grivas, Petros
    Koshkin, Vadim S.
    Chu, Xiangying
    Cole, Suzanne
    Jain, Rohit K.
    Dreicer, Robert
    Cetnar, Jeremy P.
    Sundi, Debasish
    Gartrell, Benjamin A.
    Galsky, Matthew D.
    Woo, Brianna
    Li-Ning-Tapia, Elsa
    Hahn, Noah M.
    Carducci, Michael A.
    EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (04): : 914 - 922
  • [29] A Phase II Trial of Proton Radiation Therapy With Chemotherapy for Nasopharyngeal Carcinoma
    Chan, A.
    Adams, J. A.
    Weyman, E.
    Parambi, R.
    Goldsmith, T.
    Holman, A.
    Truong, M.
    Busse, P. M.
    Delaney, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S151 - S152
  • [30] Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial
    Burmeister, Bryan H.
    Thomas, Janine M.
    Burmeister, Elizabeth A.
    Walpole, Euan T.
    Harvey, Jennifer A.
    Thomson, Damien B.
    Barbour, Andrew P.
    Gotley, David C.
    Smithers, B. Mark
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (03) : 354 - 360
12345